JP2018527386A5 - - Google Patents

Download PDF

Info

Publication number
JP2018527386A5
JP2018527386A5 JP2018514457A JP2018514457A JP2018527386A5 JP 2018527386 A5 JP2018527386 A5 JP 2018527386A5 JP 2018514457 A JP2018514457 A JP 2018514457A JP 2018514457 A JP2018514457 A JP 2018514457A JP 2018527386 A5 JP2018527386 A5 JP 2018527386A5
Authority
JP
Japan
Prior art keywords
nicotine
formulation
particles
dry powder
size
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018514457A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018527386A (ja
Filing date
Publication date
Priority claimed from US14/856,129 external-priority patent/US11224594B2/en
Application filed filed Critical
Publication of JP2018527386A publication Critical patent/JP2018527386A/ja
Publication of JP2018527386A5 publication Critical patent/JP2018527386A5/ja
Pending legal-status Critical Current

Links

JP2018514457A 2015-09-16 2016-09-15 ニコチン製剤、ならびにこれを作製および使用する方法 Pending JP2018527386A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14/856,129 US11224594B2 (en) 2015-09-16 2015-09-16 Nicotine formulations and methods of making and using the same
US14/856,129 2015-09-16
PCT/US2016/051961 WO2017048972A1 (en) 2015-09-16 2016-09-15 Nicotine formulations and methods of making and using the same

Publications (2)

Publication Number Publication Date
JP2018527386A JP2018527386A (ja) 2018-09-20
JP2018527386A5 true JP2018527386A5 (enExample) 2019-10-17

Family

ID=58257033

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018514457A Pending JP2018527386A (ja) 2015-09-16 2016-09-15 ニコチン製剤、ならびにこれを作製および使用する方法

Country Status (10)

Country Link
US (1) US11224594B2 (enExample)
EP (1) EP3349755B1 (enExample)
JP (1) JP2018527386A (enExample)
KR (1) KR102696600B1 (enExample)
CN (1) CN106539793B (enExample)
CA (1) CA2998950A1 (enExample)
IL (1) IL258139A (enExample)
MX (1) MX2018003271A (enExample)
RU (1) RU2722446C2 (enExample)
WO (1) WO2017048972A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9585835B1 (en) * 2015-09-16 2017-03-07 Sansa Corporation (Barbados) Inc. Inhalable nicotine formulations and methods of making and using the same
US10149844B2 (en) 2015-09-16 2018-12-11 Philip Morris Products S.A. Inhalable nicotine formulations, and methods of making and using thereof
MX385972B (es) * 2016-06-30 2025-03-18 Philip Morris Products Sa Partículas y composiciones de nicotina.
WO2019003118A1 (en) * 2017-06-28 2019-01-03 Philip Morris Products S.A. CONTAINER WITH PARTICLES FOR USE WITH INHALER
USD1081739S1 (en) 2021-04-06 2025-07-01 Altria Client Services Llc Die for gum forming
CN113208148B (zh) * 2021-05-12 2022-11-04 云南中烟工业有限责任公司 一种协同释放尼古丁和致香成分的超分子凝胶
US12295412B2 (en) 2022-01-28 2025-05-13 Altria Client Services Llc Oral pouch product
CN120500327A (zh) * 2022-10-27 2025-08-15 韩国烟草人参公社 用于吸入的低剂量尼古丁干粉组合物
CN120417888A (zh) * 2022-10-27 2025-08-01 韩国烟草人参公社 用于吸入的尼古丁干粉的制备方法

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5441060A (en) 1993-02-08 1995-08-15 Duke University Dry powder delivery system
US6102036A (en) * 1994-04-12 2000-08-15 Smoke-Stop Breath activated inhaler
CA2146954C (en) 1995-04-12 2008-06-17 Arthur Slutsky Breath activated nicotine inhalers
CA2265198C (en) 1998-03-11 2009-01-27 Zamel, Noe Method of producing a nicotine medicament and a medicament made by the method
US20120042886A1 (en) 1998-03-11 2012-02-23 Hanna Piskorz Method of producing a nicotine medicament and a medicament made by the method
CA2231968A1 (en) * 1998-03-11 1999-09-11 Smoke-Stop, A Partnership Consisting Of Art Slutsky Method of producing a nicotine medicament
US6234169B1 (en) 1998-08-14 2001-05-22 Arthur Slutsky Inhaler
ES2395096T3 (es) 1999-06-29 2013-02-08 Mannkind Corporation Purificación y estabilización de agentes farmacéuticos a base de péptidos y proteínas
US8256433B2 (en) 1999-07-16 2012-09-04 Aradigm Corporation Systems and methods for effecting cessation of tobacco use
US6799576B2 (en) 1999-07-16 2004-10-05 Aradigm Corporation System for effecting smoking cessation
US20080138399A1 (en) * 1999-07-16 2008-06-12 Aradigm Corporation Dual release nicotine formulations, and systems and methods for their use
WO2001049274A2 (en) 1999-12-30 2001-07-12 Chiron Corporation Methods for pulmonary delivery of interleukin-2
PE20011227A1 (es) * 2000-04-17 2002-01-07 Chiesi Farma Spa Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
MXPA03001092A (es) 2000-08-07 2003-09-25 Nektar Therapeutics Al Corp Polvos de proteina de haz de 4 helices secados por rocio, inhalables, que tienen agregacion minimizada.
EP1578422B1 (en) 2002-12-20 2007-04-11 NicoNovum AB A physically and chemically stable nicotine and micorcrystalline cellulose containing particulate material
JP2006522634A (ja) 2003-04-14 2006-10-05 ベクトゥラ・リミテッド 投与効率を向上させるデバイス及び製薬組成
US20060178394A1 (en) 2003-04-14 2006-08-10 Staniforth John N Pharmaceutical compositions comprising apomorphine for pulmonary inhalation
US20120321717A1 (en) * 2003-04-14 2012-12-20 Vectura Ltd. Devices and pharmaceutical compositions for enhancing dosing efficiency
WO2005000267A2 (en) 2003-05-28 2005-01-06 Nektar Therapeutics Spray drying of an alcoholic aqueous solution for the manufacture of a water-insoluble active agentmicroparticle with a partial or complete amino acid and/or phospholipid coat
GB0321607D0 (en) 2003-09-15 2003-10-15 Vectura Ltd Manufacture of pharmaceutical compositions
GB0410398D0 (en) 2004-05-10 2004-06-16 Arakis Ltd The treatment of respiratory disease
CA2648291A1 (en) 2006-04-04 2007-11-01 Stc.Unm Swellable particles for drug delivery
EP2086317A4 (en) 2006-12-01 2010-03-03 Aradigm Corp NICOTINE FORMULATIONS, KITS AND SYSTEMS AND METHOD FOR THEIR USE
US20080286340A1 (en) * 2007-05-16 2008-11-20 Sven-Borje Andersson Buffered nicotine containing products
GB0709811D0 (en) 2007-05-22 2007-07-04 Vectura Group Plc Pharmaceutical compositions
GB0801876D0 (en) * 2008-02-01 2008-03-12 Vectura Group Plc Suspension formulations
KR20100069333A (ko) 2008-12-16 2010-06-24 홍성엽 흡입식 경구 투여 금연 보조제
US20110268809A1 (en) 2010-04-28 2011-11-03 Paul Andrew Brinkley Nicotine-Containing Pharmaceutical Compositions
GB201113662D0 (en) 2011-08-08 2011-09-21 Prosonix Ltd Pharmaceutical compositions
US9907748B2 (en) 2011-10-21 2018-03-06 Niconovum Usa, Inc. Excipients for nicotine-containing therapeutic compositions
US9763928B2 (en) 2012-02-10 2017-09-19 Niconovum Usa, Inc. Multi-layer nicotine-containing pharmaceutical composition
US9056057B2 (en) 2012-05-03 2015-06-16 Kala Pharmaceuticals, Inc. Nanocrystals, compositions, and methods that aid particle transport in mucus
GB201215273D0 (en) 2012-08-28 2012-10-10 Kind Consumer Ltd Nicotine composition
PL2925395T3 (pl) 2012-11-28 2019-08-30 Fontem Holdings 1 B.V. Urządzenie wytwarzające aerozol kondensacyjny z ciekłej formulacji
US20140166027A1 (en) 2012-12-14 2014-06-19 Richard C. Fuisz Enhanced Delivery of Nicotine, THC, Tobacco, Cannabidiol or Base Alkaloid from an Electronic Cigarette or Other Vapor Producing Device Through Use of an Absorption Conditioning Unit
US10357054B2 (en) 2013-10-16 2019-07-23 R.J. Reynolds Tobacco Company Smokeless tobacco pastille
RU2016136348A (ru) * 2014-02-11 2018-03-16 Лэм Терапьютикс, Инк. Рапамицин для лечения лимфангиолейомиоматоза
KR20190075168A (ko) 2014-04-08 2019-06-28 필립모리스 프로덕츠 에스.에이. 니코틴 제형 및 이의 제조방법
CA2943459C (en) 2014-04-28 2023-05-02 Philip Morris Products S.A. Nicotine powder inhaler
CN106170313B (zh) 2014-04-28 2020-11-10 菲利普莫里斯生产公司 带香味尼古丁粉末吸入器
EP4603486A3 (en) * 2014-05-27 2025-10-15 R.J. Reynolds Tobacco Company Nicotine salts, co-crystals, and salt co-crystal complexes
US9968125B2 (en) 2015-01-09 2018-05-15 Philip Morris Products S.A. Nicotine—diketopiperazine microparticle formulations and methods of making the same
US9585835B1 (en) 2015-09-16 2017-03-07 Sansa Corporation (Barbados) Inc. Inhalable nicotine formulations and methods of making and using the same

Similar Documents

Publication Publication Date Title
RU2018113272A (ru) Никотиновые составы и способы их получения и применения
US10045976B2 (en) Nicotine-containing liquid formulations and uses thereof
JP5981416B2 (ja) ニコチン含有医薬組成物
KR102169734B1 (ko) 화합물 전달을 위한 방법 및 장치
CA2359813C (en) Nicotine mucosal spray
US5656255A (en) Composition to help stop smoking
EP3284467B1 (en) Nicotine-containing pharmaceutical compositions
WO2014093127A3 (en) Method of administering nicotine, thc, tobacco, cannabidiol or base alkaloid and absorption conditioning unit
JP2022088592A (ja) アルコール使用障害の処置のための組成物、装置、及び、方法
US20150216237A1 (en) Methods and devices for smoking urge relief
JP2018528966A5 (enExample)
RU2018113460A (ru) Вдыхаемые никотиновые композиции и способы их получения и применения
RU2003137595A (ru) Жевательная резинка с покрытием, содержащая никотин, способ ее получения и ее применение
MXPA04012041A (es) Una composicion liquida y regulada de nicotina para administracion pulmonar.
JP2011520911A5 (enExample)
MX2010011929A (es) Composiciones de comprimidos de nicotina.
JP2013224331A5 (enExample)
JP2014530871A (ja) ニコチン含有治療用組成物のための賦形剤
US11006661B2 (en) Cigarette-like device for administration of substances
FI3551189T3 (fi) Alpratsolaami epilepsian hoitoon
RU2018113274A (ru) Система и способ регулирования резкого привкуса сухих порошковых составов на основе никотина
WO2007144081A3 (de) Raucherentwöhnungs-kombinationswafer
JP6531990B2 (ja) 心肺血行動態を改善するための無機亜硝酸塩
JP2009536183A (ja) 依存症の治療におけるタバコ葉の水性抽出物とそれの使用
HK1250015A1 (zh) 镇咳药组合物和方法